Scientific Learning (SCIL) 10-Q 13 Nov 13 2013 Q3 Quarterly report Financial data

Document_And_Entity_Informatio

Document And Entity Information	9 Months Ended
	Sep. 30, 2013	Nov. 06, 2013
Document And Entity Information [Abstract]	'	'
Document Type	'10-Q	'
Amendment Flag	'false	'
Document Period End Date	30-Sep-13	'
Document Fiscal Period Focus	'Q3	'
Document Fiscal Year Focus	'2013	'
Entity Registrant Name	'SCIENTIFIC LEARNING CORP	'
Trading Symbol	'scil	'
Entity Central Index Key	'0001042173	'
Entity Current Reporting Status	'Yes	'
Current Fiscal Year End Date	'--12-31	'
Entity Filer Category	'Smaller Reporting Company	'
Entity Common Stock, Shares Outstanding	'	23,737,580

Condensed_Consolidated_Balance

Condensed Consolidated Balance Sheets (USD $)	Sep. 30, 2013	Dec. 31, 2012
In Thousands, unless otherwise specified
Assets	'	'
Cash and cash equivalents	$2,887	$2,272
Accounts receivable, net of allowance for doubtful accounts of $49 and $52, respectively	2,751	2,446
Prepaid expense and other current assets	762	1,484
Total current assets	6,400	6,202
Property and equipment, net	1,227	2,028
Goodwill	4,568	4,568
Other assets	1,048	260
Total assets	13,243	13,058
Liabilities and stockholders’ equity (net capital deficiency)	'	'
Accounts payable	216	715
Accrued liabilities	1,849	1,981
Loan payable	'	800
Deferred revenue, short-term	10,634	10,964
Total current liabilities	12,699	14,460
Deferred revenue, long-term	1,203	2,521
Long term debt	4,368	'
Warrant liability	852	534
Other liabilities	700	771
Total liabilities	19,822	18,286
Commitments and contingencies (see Note 8 to the condensed consolidated financial statements)	'	'
Stockholders’ equity (net capital deficiency):	'	'
Common stock $0.001 par value: 40,000,000 authorized, 23,738,516 and 23,442,837 shares issued and outstanding, respectively, and additional paid-in capital	96,481	95,839
Accumulated deficit	-103,059	-101,069
Accumulated other comprehensive income (loss)	-1	2
Total stockholders' equity (net capital deficiency)	-6,579	-5,228
Total liabilities and stockholders' equity (net capital deficiency)	$13,243	$13,058

Condensed_Consolidated_Balance1

Condensed Consolidated Balance Sheets (Parenthetical) (USD $)	Sep. 30, 2013	Dec. 31, 2012
In Thousands, except Share data, unless otherwise specified
Condensed Consolidated Balance Sheets [Abstract]	'	'
Accounts receivable allowance for doubtful accounts	$49	$52
Common stock, par value	$0.00	$0.00
Common stock, shares authorized	40,000,000	40,000,000
Common stock, shares issued	23,738,516	23,442,837
Common stock, shares outstanding	23,738,516	23,442,837

Condensed_Consolidated_Stateme

Condensed Consolidated Statements Of Operations (USD $)	3 Months Ended		9 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012
Revenues:	'	'	'	'
Subscription	$1,686	$1,200	$4,909	$2,884
License	1,057	2,018	2,472	6,918
Service and support	2,477	3,610	8,647	11,260
Total revenues	5,220	6,828	16,028	21,062
Cost of revenues:	'	'	'	'
Cost of subscription	315	288	931	793
Cost of license	64	236	200	735
Cost of service and support	794	1,322	2,619	4,752
Total cost of revenues	1,173	1,846	3,750	6,280
Gross profit	4,047	4,982	12,278	14,782
Operating expenses:	'	'	'	'
Sales and marketing	2,297	3,367	6,938	12,634
Research and development	959	1,395	2,966	5,898
General and administrative	1,487	1,948	4,150	6,137
Restructuring	'	1,462	'	1,462
Total operating expenses	4,743	8,172	14,054	26,131
Operating loss	-696	-3,190	-1,776	-11,349
Interest and other income (expense), net	-209	1,030	-140	1,095
Loss before provision for income tax	-905	-2,160	-1,916	-10,254
Provision for income taxes	27	86	74	169
Net loss	($932)	($2,246)	($1,990)	($10,423)
Net loss per share:	'	'	'	'
Basic net loss per share	($0.04)	($0.10)	($0.08)	($0.48)
Diluted net loss per share	($0.04)	($0.10)	($0.08)	($0.48)
Weighted average shares used in computation of per share data:	'	'	'	'
Basic weighted average shares outstanding	23,739	23,368	23,633	21,933
Diluted weighted average shares outstanding	23,739	23,368	23,633	21,933

Condensed_Consolidated_Stateme1

Condensed Consolidated Statements Of Comprehensive Income (Loss) (USD $)	3 Months Ended		9 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012
Condensed Consolidated Statements Of Comprehensive Income (Loss) [Abstract]	'	'	'	'
Net loss	($932)	($2,246)	($1,990)	($10,423)
Other comprehensive income (loss):	'	'	'	'
Foreign currency translation adjustments, net of tax	5	'	-3	'
Comprehensive loss	($927)	($2,246)	($1,993)	($10,423)

Condensed_Consolidated_Stateme2

Condensed Consolidated Statements Of Cash Flows (USD $)	9 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2013	Sep. 30, 2012
Operating Activities:	'	'
Net loss	($1,990)	($10,423)
Adjustments to reconcile net loss to cash used in operating activities:	'	'
Depreciation and amortization	1,021	1,866
Investment impairment charge	'	200
Fixed asset impairment charge	32	'
Stock-based compensation expense	607	615
Paid-in-kind interest expense	277	'
Amortization of debt discount and deferred debt issuance cost	219	'
Decrease in fair value of warrant	-380	-1,356
Changes in operating assets and liabilities:	'	'
Accounts receivable	-305	-177
Prepaid expenses and other current assets	722	889
Other assets	-770	25
Accounts payable	-499	-374
Accrued liabilities	-132	-364
Deferred revenue	-1,648	-1,582
Other liabilities	-71	-126
Net cash used in operating activities	-2,917	-10,807
Investing Activities:	'	'
Purchases of property and equipment and additions to capitalized software	-182	-476
Net cash used in investing activities	-182	-476
Financing Activities:	'	'
Borrowings under bank line of credit	2,300	7,897
Repayment of borrowings under bank line of credit	-3,100	-6,500
Proceeds from exercise of options	37	152
Proceeds from issuance of common stock, net	'	6,512
Proceeds from issuance of subordinated debt	4,600	'
Debt issuance cost	-118	'
Net cash paid for common stock issued	-2	-32
Net cash provided by financing activities	3,717	8,029
Effect of exchange rate changes on cash and cash equivalents	-3	'
Increase (decrease) in cash and cash equivalents	615	-3,254
Cash and cash equivalents at beginning of period	2,272	5,871
Cash and cash equivalents at end of period	2,887	2,617
Supplemental disclosure of cash flow information	'	'
Cash paid for income taxes	8	32
Cash paid for interest	27	48
Non-cash financing activity	'	'
Issuance of common stock warrants in connection with common stock offering	'	2,368
Issuance of common stock warrants in connection with subordinated debt financing	$698	'

Summary_Of_Significant_Account

Summary Of Significant Accounting Policies	9 Months Ended
	Sep. 30, 2013
Summary Of Significant Accounting Policies [Abstract]	'
Summary Of Significant Accounting Policies	'
	1. Summary of Significant Accounting Policies
	Description of Business
	Scientific Learning Corporation (the “Company”) develops, distributes and licenses technology that accelerates learning by improving the processing efficiency of the brain.
	The Company’s patented products build learning capacity by rigorously and systematically applying neuroscience-based learning principles to improve the fundamental cognitive skills required to read and learn. To facilitate the use of the Company’s products, the Company offers a variety of on-site and remote professional and technical services, as well as phone, email and web-based support.  The Company sells primarily to K-12 schools in the United States through a direct sales force.
	All of the Company’s activities are in one operating segment.
	The Company was incorporated in 1995 in the State of California and was reincorporated in 1997 in the State of Delaware.
	Basis of Accounting and Liquidity
	The Company’s cash and cash equivalents were $2.9 million at September 30, 2013, compared to cash and cash equivalents of $2.3 million at December 31, 2012.  In the first nine months of 2013, we have used $2.9 million of cash in operations.
	The Company expects to continue to fund its operations primarily from its current cash balances and the issuance of subordinated debt and warrants that was completed on April 5, 2013.  The Company is also exploring opportunities to monetize a portion of its patent portfolio through sales or licenses of some of its patents, though it may not be successful in doing so.  This will require the Company to achieve certain level of booked sales, cash collections and expenses.  The Company’s ability to continue as a going concern is dependent upon many factors.  If the Company is unable to achieve the needed levels of booked sales and cash collections, it expects to further reduce expenses to ensure that it will have sufficient liquidity to continue to fund its operations through at least September 30, 2014.  Reducing expenses substantially below current levels could have a negative impact on the Company’s future growth potential.  In addition, the Company may be required to sell assets, issue additional equity securities or incur additional debt.  The Company may not be able to accomplish any of these alternatives.
	On April 5, 2013, the Company issued $4.6 million of subordinated debt securities and warrants to purchase an aggregate of 1,846,940 shares of the Company’s common stock to a group of its current investors.  The notes issued pursuant to the subordinated note and warrant purchase agreement bear simple interest at a rate of 12% per annum.  From the issuance date through the first anniversary thereof, the Company will pay accrued and unpaid interest quarterly in arrears by increasing the principal amount of each note and thereafter will pay accrued and unpaid interest in cash in arrears on July 31, 2014, November 30, 2014 and April 5, 2015.  The notes mature on April 5, 2015.  The note and warrant purchase agreements contain customary affirmative and negative covenants, including notification and information covenants and covenants restricting the Company’s ability to merge or liquidate, incur debt, dispose of assets, incur liens, declare dividends or enter into transactions with affiliates.  The note and warrant purchase agreements also require the Company to repay the notes upon the occurrence of a change of control (as defined in the note and warrant purchase agreement) at 101% of the principal amount thereof plus accrued and unpaid interest.
	On August 9, 2013, the Company amended its credit line with Comerica. The Company’s amended line of credit has an effective limit of $4 million.  In the amendment, Comerica agreed to waive past covenant violations and agreed not to measure compliance with the minimum bookings covenant until such time as the Company seeks to borrow against the line of credit. The amendment also requires that certain financial covenants be renegotiated prior to the Company borrowing against the line of credit.  The Company currently intends to extend its line of credit beyond March 2014 and renegotiate its financial covenants.  There is no assurance that the Company would be able to successfully do so.
	As of September 30, 2013,  the Company had no borrowings outstanding on the line of credit.  During the months ending January 31, 2013, February 28, 2013, May 31, 2013 and June 30, 2013 the Company was not in compliance with its line of credit covenants.  Comerica granted the Company waivers of the covenant violations for these periods.  Under the terms of the August 9, 2013 amendment to the line of credit, Comerica is not currently measuring the Company’s compliance with the minimum bookings covenants.  As of September 30, 2013, the Company is in compliance with the covenants that are being measured by Comerica.
	Use of Estimates
	The preparation of consolidated financial statements, in conformity with accounting principles generally accepted in the United States, requires management to make certain estimates and assumptions that affect the reported amounts of assets and liabilities as of the date of the financial statements as well as the reported amounts of revenues and expenses during the periods presented. To the extent that there are material differences between these estimates and actual results, the Company’s condensed consolidated financial statements could be affected.
	Principles of Consolidation
	The condensed consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries in Shanghai, China and Puerto Rico.  All significant intercompany balances and transactions have been eliminated in consolidation.
	Interim Financial Information
	The interim consolidated financial information as of September 30, 2013 and for the three and nine months ended September 30, 2013 and 2012 is unaudited, and includes all necessary adjustments, which consisted only of normal recurring adjustments, for a fair presentation of the Company’s financial position at such dates and the Company’s results of operations and cash flows for those periods. The balance sheet as of December 31, 2012 has been derived from audited consolidated financial statements at that date but does not include all of the information and notes required by generally accepted accounting principles (“GAAP”) for annual financial statements. In addition, the results of operations for the three and nine months ended September 30, 2013 are not necessarily indicative of the results for the entire year ending December 31, 2013, or for any other period.
	These unaudited, condensed consolidated financial statements and notes should be read in conjunction with the Company’s audited consolidated financial statements and notes thereto and Part II, Item 7 – “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” contained in the Company’s Annual Report on Form 10-K for the year ended December 31, 2012, filed with the Securities and Exchange Commission.
	Cash Pledge
	As of September 30, 2013, the Company pledged cash collateral in the amount of $150,000, which relates to a letter of credit issued to American Express Corporation.  This pledge is part of the 4th amendment of the Company’s line of credit with Comerica signed on August 9, 2013.  See Note 6.
	Software and Web Site Development Costs
	The Company capitalizes certain software development costs incurred subsequent to the establishment of technological feasibility and amortizes those costs over the estimated lives of the related products. The annual amortization is computed using the straight-line method over the remaining estimated economic life of the product. Technological feasibility is established upon completion of a working model.  In the three months ended September 30, 2013, the Company did not capitalize any costs relating to new products that had reached technological feasibility.  In the nine months ended September 30, 2013, the Company capitalized $30,000 of costs relating to new products that had reached technological feasibility.  In the three and nine months ended September 30, 2012, the Company capitalized zero and $56,000 of costs relating to new products that had reached technological feasibility, respectively.  For the three and nine months ended September 30, 2013, the Company recorded amortization expense of $12,000 and $70,000, respectively.  For the three and nine months ended September 30, 2012, the Company recorded amortization expense of $44,000 and $127,000, respectively.
	The Company also capitalizes costs related to internal use software and website application, infrastructure development and content development costs.  Costs related to preliminary project activities and post implementation activities are expensed as incurred.  Costs incurred during the application development stage are capitalized.  Internal-use software is amortized on a straight line basis over its estimated useful life, generally three years. Management evaluates the useful lives of these assets on an annual basis and tests for impairment whenever events or changes in circumstances occur that could impact the recoverability of these assets. The capitalized costs are included in “Property and equipment” in the condensed consolidated balance sheet. In each case the software or website is for internal needs, and the Company does not plan to market the software externally. For the three and nine months ended September 30, 2013, the Company capitalized approximately $14,000 and $156,000 of software and website development costs, respectively.  For the three and nine months ended September 30, 2012, the Company capitalized approximately $10,000 and $317,000 of software and website development costs, respectively.  For the three and nine months ended September 30, 2013, the Company recorded amortization expense of $175,000 and $519,000, respectively.  For the three and nine months ended September 30, 2012, the Company recorded amortization expense of $235,000 and $682,000, respectively.
	Net Loss Per Share
	Basic net loss per share is computed using the weighted-average number of common shares outstanding during the period.  Diluted net loss per share reflects the potential dilution of securities by adding common stock equivalents (computed using the treasury stock method) to the weighted-average number of common shares outstanding during the period, if dilutive. For the three and nine months ended September 30, 2013, stock options and awards exercisable for 2.2 million and 2.0 million shares of common stock along with common stock warrants exercisable for 4.4 million shares of common stock were excluded from the calculation of diluted net loss per share because their effect is anti-dilutive.
	Recent Accounting Pronouncements
	There are no material changes from the pronouncements disclosed in part II, Item 8 – “Financial Statements and Supplementary Data” of our Annual Report on Form 10-K for the year ended December 31, 2012.

Warrant_Liability

Warrant Liability	9 Months Ended
	Sep. 30, 2013
Warrant Liability [Abstract]	'
Warrant Liability	'
	2. Warrant Liability
	In connection with the Company’s private common stock offering that closed on March 28, 2012, the Company issued warrants (“PIPE warrants”) to purchase an aggregate of 2,505,852 shares of common stock.  The warrants have an exercise price of $1.82 per share and expire five years from the date of issuance. In addition, the warrants contain a cash settlement provision that may be triggered upon request by the warrant holders if the Company is acquired or a merger event, as defined by the warrant agreement, occurs.
	In addition, in connection with the Company’s subordinated debt financing completed on April 5, 2013, the Company issued warrants (“Sub-debt warrants”) to purchase an aggregate of 1,846,940 shares of common stock.  The warrants have an exercise price of $1.03 per share and expire three years from the date of issuance. The warrants contain a cash settlement provision that may be triggered upon request by the warrant holders if the Company is acquired or in the event of a merger, as defined by the warrant agreement, occurs.
	Under the FASB Accounting Standards Codification (“ASC”) Topic 815, Derivatives and Hedging, an equity contract that can be settled in cash at the request of the holder must be classified as an asset or a liability. The accounting guidance also requires that the warrants be re-measured at fair value at each reporting date, with the change in fair value recorded in the Company’s condensed consolidated statement of operations.
	At September 30, 2013, the estimated fair value of the PIPE warrants was approximately $444,000 and is recorded as a liability on the Company’s condensed consolidated balance sheet.  For the three and nine months ended September 30, 2013, there was a decrease of approximately $20,000 and $90,000, respectively, to the warrant liability which was recorded as income, in interest and other income on the condensed consolidated statements of operations.
	On April 5, 2013, the initial estimated fair value of the Sub-debt warrants was approximately $698,000.  At September 30, 2013, the estimated fair value of the Sub-debt warrants was approximately $408,000 and is recorded as a liability on the Company’s condensed consolidated balance sheet.  For the three and nine months ended September 30, 2013, there was a decrease of approximately $22,000 and $290,000, respectively, to the warrant liability which was recorded as income, in interest and other income on the condensed consolidated statements of operations.
	The fair value was estimated using the Black-Scholes-Merton option pricing model, which requires the input of highly subjective assumptions as determined by management. To the extent these assumptions change in future periods, the fair value of the common stock warrants may increase or decrease and the change in fair value will be recorded in our results of operations.  As of September 30, 2013, all common stock warrants were outstanding.

Fair_Value_Measurements

Fair Value Measurements	9 Months Ended
	Sep. 30, 2013
Fair Value Measurements [Abstract]	'
Fair Value Measurements	'
	3. Fair Value Measurements
	The Company generally invests its excess cash in money market funds.  Cash and cash equivalents represent highly liquid instruments with insignificant interest rate risk and original maturities of three months or less.
	FASB prescribes a three-tier fair value hierarchy, categorizing the inputs used to measure fair value.  The hierarchy can be described as follows: Level 1- observable inputs such as quoted prices in active markets; Level 2- inputs other than the quoted prices in active markets that are observable either directly or indirectly; and Level 3- unobservable inputs for which there is little or no market data, which require the reporting entity to develop its own assumptions.
	Cash equivalents consist of money market funds that have original maturities of 90 days or less.  These instruments are valued using quoted prices in active markets and as such are classified in Level 1 of the fair value hierarchy.  The Company has no Level 2 financial assets as of September 30, 2013.
	At September 30, 2013, the Company had outstanding warrants to purchase shares of its common stock, which were issued on March 28, 2012 and April 5, 2013.  The warrants are measured at fair value each reporting period and are classified as liabilities with a fair value of $0.9 million at September 30, 2013.  The warrants are valued using the Black-Scholes-Merton option pricing model using valuation assumptions determined by management and are classified as Level 3 in the Company’s fair value hierarchy.
	As of September 30, 2013, the Company used the following assumptions when determining the fair value of the PIPE warrants:
	Expected life (in years)	3.5
	Risk-free interest rate	0.82	%
	Dividend yield	0	%
	Expected volatility	95	%
	The Company assessed the sensitivity of the fair value of the PIPE warrants with respect to the assumptions above and noted that a change in the price of our common stock of 10% would affect the fair value of the warrants by 16% or $70,000.  A change in volatility of 10% would affect the fair value of the warrants by 18% or $80,000.
	As of September 30, 2013, the Company used the following assumptions when determining the fair value of the Sub-debt warrants:
	Expected life (in years)	2.6
	Risk-free interest rate	0.48	%
	Dividend yield	0	%
	Expected volatility	109	%
	The Company assessed the sensitivity of the fair value of the Sub-debt warrants with respect to the assumptions above and noted that a change in the price of our common stock of 10% would affect the fair value of the warrants by 15% or $70,000.  A change in volatility of 10% would affect the fair value of the warrants by 14% or $60,000.
	The following table summarizes the changes in fair value for all outstanding common stock warrants for the nine months ended September 30, 2013  (in thousands):
		Nine Months Ended September 30, 2013
	Balance at December 31, 2012	$	534
	Issuance of warrants with subordinated debt financing		698
	Total change in fair value		-380
	Balance at September 30, 2013	$	852
	The following table represents the fair value hierarchy for assets and liabilities, which are measured at fair value on a recurring basis as of September 30, 2013  (in thousands):
		30-Sep-13
		Level 1		Level 2		Level 3		Total
	Assets:
	Money market instruments	$	650	$	-	$	-	$	650
	Liabilities:
	Common stock warrants	$	-	$	-	$	852	$	852

StockBased_Compensation

Stock-Based Compensation	9 Months Ended
	Sep. 30, 2013
Stock-Based Compensation [Abstract]	'
Share-Based Compensation	'
	4. Stock-Based Compensation
	The Company did not grant any options to purchase shares of common stock during the three months ended September 30, 2013.  The Company granted 143,333 restricted stock units during the three months ended September 30, 2013.  The Company granted options to purchase 96,000 shares of common stock and no restricted stock units during the three months ended September 30, 2012. The Company granted options to purchase 583,750 shares of common stock and 268,928 restricted stock units during the nine months ended September 30, 2013.  The Company granted options to purchase 278,000 shares of common stock and 113,257 restricted stock units during the nine months ended September 30, 2012.
	The fair value of each option award is estimated on the date of grant using a Black-Scholes-Merton option pricing model with subjective assumptions, developed as follows:
	Expected volatility – Based on the historical prices of common stock over the expected life of each option.
	Expected life – Based on the history of option exercise and cancellation activity of the options.
	Risk-free interest rate – Based on the U.S. Treasury yield curve in effect at the time of grants for periods corresponding with the expected life of the options.
	Dividend yield – As the Company has not paid, nor does it currently plan to pay, dividends in the future, the assumed dividend yield is zero.
	The fair value of stock options granted was estimated using the following weighted-average assumptions:
		Three months ended September 30,		Nine months ended September 30,
		2013	2012	2013	2012
	Expected life (in years)	n/a	5.5	5.5	5.5
	Risk-free interest rate	n/a	0.8%	0.9%	1.0%
	Dividend yield	n/a	0%	0%	0%
	Expected volatility	n/a	63%	74%	63%

Warranties_And_Indemnification

Warranties And Indemnification	9 Months Ended
	Sep. 30, 2013
Warranties And Indemnification [Abstract]	'
Warranties And Indemnification	'
	5. Warranties and Indemnification
	The Company generally provides a warranty that the Company’s software products will substantially operate as described in the manuals and guides that accompany the software for a period of 90 days. The warranty does not apply in the event of misuse, accident, and certain other circumstances. To date, the Company has not incurred any material costs associated with these warranties and has no accrual for such items at September 30, 2013.
	From time to time, the Company enters into contracts that require the Company, upon the occurrence of certain contingencies, to indemnify parties against third party claims. These contingent obligations primarily relate to (i) claims against the Company’s customers for violation of third party intellectual property rights caused by the Company’s products; (ii) claims resulting from personal injury or property damage resulting from the Company’s activities or products; (iii) claims by the Company’s office lessor arising out of the use of the premises; and (iv) agreements with the Company’s officers and directors under which the Company may be required to indemnify such persons for liabilities arising out of their activities on behalf of the Company. Because the obligated amounts for these types of agreements are not explicitly stated, the overall maximum amount of these obligations cannot be reasonably estimated. Additionally, the Company is not aware of any claims under such indemnification provisions.  Accordingly, no liabilities have been recorded for these obligations as of September 30, 2013.

Loan_Payable

Loan Payable	9 Months Ended
	Sep. 30, 2013
Loan Payable [Abstract]	'
Loan Payable	'
	6. Loan Payable
	As of September 30, 2013, the Company had no borrowings outstanding on the line of credit.  However, during the months ending January 31, 2013, February 28, 2013, May 31, 2013 and June 30, 2013, the Company was not in compliance with its covenants.  Comerica granted the Company waivers of the covenant violations for these periods.
	On August 9, 2013, the Company entered into an amendment (the “Fourth Amendment”) to its amended and restated loan and security agreement, dated as of February 9, 2012 (as amended), by and between the Company and Comerica Bank.  In the Fourth Amendment, Comerica agreed to waive past covenant violations and agreed not to measure compliance with the minimum bookings covenant until such time as the Company seeks to borrow against the line of credit. As of September 30, 2013, the Company was in compliance with the covenants that are being measured by Comerica.    The Fourth Amendment also requires that the financial covenants be renegotiated prior to the Company borrowing against the line of credit.  The Company currently intends to extend its line of credit beyond March 2014 and renegotiate its financial covenants.  There is no assurance that the Company would be able to successfully do so.

Provision_For_Income_Taxes

Provision For Income Taxes	9 Months Ended
	Sep. 30, 2013
Provision For Income Taxes [Abstract]	'
Provision For Income Taxes	'
	7. Provision for Income Taxes
	In the three and nine months ended September 30, 2013, the Company recorded income tax expense of $27,000 and $74,000, respectively. In the three and nine months ended September 30, 2012 the Company recorded income tax expense of $86,000 and $169,000, respectively.  The tax expense for the three and nine months ended September 30, 2013 and 2012 consists primarily of deferred tax expense relating to the amortization of acquired goodwill, current state tax expense and current foreign tax expense.
	The Company has established and continues to maintain a full valuation allowance against its deferred tax assets as the Company does not believe that the realization of those assets is more likely than not.
	At September 30, 2013, the Company has unrecognized tax benefits of approximately $2.7 million.    The Company does not have unrecognized tax benefits that, if recognized, would affect the effective tax rate. The Company does not believe there will be any material changes in the unrecognized tax positions over the next twelve months. Interest and penalty costs related to unrecognized tax benefits are insignificant and classified as a component of “Provision for income taxes” in the accompanying statements of operations. The Company files income tax returns in the U.S. federal jurisdiction,  various state jurisdictions including Puerto Rico, and China. Tax returns remain open to examination by the appropriate governmental agencies for tax years 2008 to 2012. The federal and state taxing authorities may choose to audit tax returns for tax years beyond the statute of limitation period due to significant tax attribute carryforwards from prior years, making adjustments only to carryforward attributes. The Company is not currently under audit in any major tax jurisdiction.

Commitments_And_Contingencies

Commitments And Contingencies	9 Months Ended
	Sep. 30, 2013
Commitments And Contingencies [Abstract]	'
Commitments And Contingencies	'
	8. Commitments and Contingencies
	The Company leases office space and equipment under non-cancelable operating leases with various expiration dates.
	In addition, the Company leases certain equipment under capital lease arrangements that extends through 2014 for the amounts of $101,000 in 2013 and $25,000 in 2014. The Company also makes royalty payments to the institutions who participated in the original research that produced its initial products. The Company’s minimum royalty payments are $150,000 per year.
	At September 30, 2013, the Company's future minimum lease payments and future payments under its royalty agreements are as follows (in thousands):
		Remaining 2013		2014		2015		2016		2017 and thereafter		Total
	Contractual Obligations:
	Lease obligations	$	197	$	670	$	624	$	229	$	155	$	1,875
	Minimum royalty obligations		-		150		-		-		-		150
	Total	$	197	$	820	$	624	$	229	$	155	$	2,025

Restructuring

Restructuring	9 Months Ended
	Sep. 30, 2013
Restructuring [Abstract]	'
Restructuring	'
	9. Restructuring
	During the third quarter of 2012, as part of the Company’s strategy to better align its costs and organizational structure with the current economic environment and reduce losses, the Company implemented two reductions in its workforce totaling 30% compared to staff levels at the end of the second quarter of 2012.  Employees were notified in July and September 2012.
	As a result, the Company recorded severance costs of $1.5 million, of which the Company paid $1.1 million during fiscal 2012.  As of September 30, 2013,  $0.1 million of severance remains recorded within Accrued Liabilities and Other Liabilities.  A significant portion of this liability is related to severance payments for one officer that departed the Company in the third quarter of 2012, but is payable over an extended period of time.  This amount is expected to be fully paid by the first quarter of 2015.
	Accrued costs are shown in the following table (in thousands):
		As of September 30, 2013
	Accrued at December 31, 2012	$	285
	Charges		-
	Cash payments		-141
	Adjustments		-21
	Accrued at September 30, 2013	$	123

Long_Term_Debt

Long Term Debt	9 Months Ended
	Sep. 30, 2013
Long Term Debt [Abstract]	'
Long Term Debt	'
	10.  Long-term debt
	On April 5, 2013, the Company issued $4.6 million of subordinated debt securities and warrants to purchase an aggregate of 1,846,940 shares of the Company’s common stock, to a group of its current investors.  The notes issued pursuant to the subordinated note and warrant purchase agreement bear simple interest at a rate of 12% per annum.  From the issuance date through the first anniversary thereof, the Company will pay accrued and unpaid interest quarterly in arrears by increasing the principal amount of each note (“PIK Interest”) and thereafter will pay accrued and unpaid interest in cash in arrears on July 31, 2014, November 30, 2014 and the final payment date.  The notes mature on April 5, 2015.  The note and warrant purchase agreement contains customary affirmative and negative covenants, including notification and information covenants and covenants restricting the Company’s ability to merge or liquidate, incur debt, dispose of assets, incur liens, declare dividends or enter into transactions with affiliates.  As of September 30, 2013, the Company was in compliance with all covenants related to the subordinated debt.  The note and warrant purchase agreement also requires the Company to repay the notes upon the occurrence of a change of control (as defined in the note and warrant purchase agreement) at 101% of the principal amount thereof plus accrued and unpaid interest.
	The total value allocated to the warrants was approximately $698,000 and was recorded as a debt discount against the proceeds of the notes and will be amortized to interest expense over term of the notes.  See Note 2.  The aggregate debt issuance costs associated with the subordinated debt financing were $118,000, which are comprised of outside legal costs. These costs have been capitalized as debt issuance costs, included in Other Assets and will be amortized as interest expense over the life of the notes.    For the three and nine months ended September 30, 2013, the Company recorded amortization expense of $15,000 and $30,000, respectively.
	At September 30, 2013, the Company's subordinated notes payable is made up of the following (in thousands):
			As of September 30, 2013
	Subordinated notes payable	$	4,600
	Deferred debt discount		-509
	Accrued PIK interest		277
	Long-term debt	$	4,368
	11

Subsequent_Events

Subsequent Events	9 Months Ended
	Sep. 30, 2013
Subsequent Events [Abstract]	'
Subsequent Events	'
	11.  Subsequent Events
	On November 5, 2013, Company Management committed to a plan to discontinue the Company’s development operations in China.  The effected plan will include a reduction in the Company’s workforce intended to improve the efficiency of its development operations, better align its costs and organization structure with the current economic environment and improve its profitability.  The Company notified the employees affected by the workforce reduction on November 5, 2013.  The Company expects to complete the exit plan by June 30, 2014.  The Company estimates that the costs incurred in connection with the exit activity will be approximately $200,000 to $250,000, which consists of estimated severance costs, contract termination costs and legal fees expected to be expensed in the fourth quarter of 2013.  Substantially all of that charge will result in cash expenditures.

Summary_Of_Significant_Account1

Summary Of Significant Accounting Policies (Policy)	9 Months Ended
	Sep. 30, 2013
Summary Of Significant Accounting Policies [Abstract]	'
Description Of Business	'
	Description of Business
	Scientific Learning Corporation (the “Company”) develops, distributes and licenses technology that accelerates learning by improving the processing efficiency of the brain.
	The Company’s patented products build learning capacity by rigorously and systematically applying neuroscience-based learning principles to improve the fundamental cognitive skills required to read and learn. To facilitate the use of the Company’s products, the Company offers a variety of on-site and remote professional and technical services, as well as phone, email and web-based support.  The Company sells primarily to K-12 schools in the United States through a direct sales force.
	All of the Company’s activities are in one operating segment.
	The Company was incorporated in 1995 in the State of California and was reincorporated in 1997 in the State of Delaware.
Basis Of Accounting And Liquidity	'
	Basis of Accounting and Liquidity
	The Company’s cash and cash equivalents were $2.9 million at September 30, 2013, compared to cash and cash equivalents of $2.3 million at December 31, 2012.  In the first nine months of 2013, we have used $2.9 million of cash in operations.
	The Company expects to continue to fund its operations primarily from its current cash balances and the issuance of subordinated debt and warrants that was completed on April 5, 2013.  The Company is also exploring opportunities to monetize a portion of its patent portfolio through sales or licenses of some of its patents, though it may not be successful in doing so.  This will require the Company to achieve certain level of booked sales, cash collections and expenses.  The Company’s ability to continue as a going concern is dependent upon many factors.  If the Company is unable to achieve the needed levels of booked sales and cash collections, it expects to further reduce expenses to ensure that it will have sufficient liquidity to continue to fund its operations through at least September 30, 2014.  Reducing expenses substantially below current levels could have a negative impact on the Company’s future growth potential.  In addition, the Company may be required to sell assets, issue additional equity securities or incur additional debt.  The Company may not be able to accomplish any of these alternatives.
	On April 5, 2013, the Company issued $4.6 million of subordinated debt securities and warrants to purchase an aggregate of 1,846,940 shares of the Company’s common stock to a group of its current investors.  The notes issued pursuant to the subordinated note and warrant purchase agreement bear simple interest at a rate of 12% per annum.  From the issuance date through the first anniversary thereof, the Company will pay accrued and unpaid interest quarterly in arrears by increasing the principal amount of each note and thereafter will pay accrued and unpaid interest in cash in arrears on July 31, 2014, November 30, 2014 and April 5, 2015.  The notes mature on April 5, 2015.  The note and warrant purchase agreements contain customary affirmative and negative covenants, including notification and information covenants and covenants restricting the Company’s ability to merge or liquidate, incur debt, dispose of assets, incur liens, declare dividends or enter into transactions with affiliates.  The note and warrant purchase agreements also require the Company to repay the notes upon the occurrence of a change of control (as defined in the note and warrant purchase agreement) at 101% of the principal amount thereof plus accrued and unpaid interest.
	On August 9, 2013, the Company amended its credit line with Comerica. The Company’s amended line of credit has an effective limit of $4 million.  In the amendment, Comerica agreed to waive past covenant violations and agreed not to measure compliance with the minimum bookings covenant until such time as the Company seeks to borrow against the line of credit. The amendment also requires that certain financial covenants be renegotiated prior to the Company borrowing against the line of credit.  The Company currently intends to extend its line of credit beyond March 2014 and renegotiate its financial covenants.  There is no assurance that the Company would be able to successfully do so.
	As of September 30, 2013,  the Company had no borrowings outstanding on the line of credit.  During the months ending January 31, 2013, February 28, 2013, May 31, 2013 and June 30, 2013 the Company was not in compliance with its line of credit covenants.  Comerica granted the Company waivers of the covenant violations for these periods.  Under the terms of the August 9, 2013 amendment to the line of credit, Comerica is not currently measuring the Company’s compliance with the minimum bookings covenants.  As of September 30, 2013, the Company is in compliance with the covenants that are being measured by Comerica.
Use Of Estimates	'
	Use of Estimates
	The preparation of consolidated financial statements, in conformity with accounting principles generally accepted in the United States, requires management to make certain estimates and assumptions that affect the reported amounts of assets and liabilities as of the date of the financial statements as well as the reported amounts of revenues and expenses during the periods presented. To the extent that there are material differences between these estimates and actual results, the Company’s condensed consolidated financial statements could be affected.
Principles Of Consolidation	'
	Principles of Consolidation
	The condensed consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries in Shanghai, China and Puerto Rico.  All significant intercompany balances and transactions have been eliminated in consolidation.
Interim Financial Information	'
	Interim Financial Information
	The interim consolidated financial information as of September 30, 2013 and for the three and nine months ended September 30, 2013 and 2012 is unaudited, and includes all necessary adjustments, which consisted only of normal recurring adjustments, for a fair presentation of the Company’s financial position at such dates and the Company’s results of operations and cash flows for those periods. The balance sheet as of December 31, 2012 has been derived from audited consolidated financial statements at that date but does not include all of the information and notes required by generally accepted accounting principles (“GAAP”) for annual financial statements. In addition, the results of operations for the three and nine months ended September 30, 2013 are not necessarily indicative of the results for the entire year ending December 31, 2013, or for any other period.
	These unaudited, condensed consolidated financial statements and notes should be read in conjunction with the Company’s audited consolidated financial statements and notes thereto and Part II, Item 7 – “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” contained in the Company’s Annual Report on Form 10-K for the year ended December 31, 2012, filed with the Securities and Exchange Commission.
Cash Pledge	'
	Cash Pledge
	As of September 30, 2013, the Company pledged cash collateral in the amount of $150,000, which relates to a letter of credit issued to American Express Corporation.  This pledge is part of the 4th amendment of the Company’s line of credit with Comerica signed on August 9, 2013.  See Note 6.
Software And Web Site Development Costs	'
	Software and Web Site Development Costs
	The Company capitalizes certain software development costs incurred subsequent to the establishment of technological feasibility and amortizes those costs over the estimated lives of the related products. The annual amortization is computed using the straight-line method over the remaining estimated economic life of the product. Technological feasibility is established upon completion of a working model.  In the three months ended September 30, 2013, the Company did not capitalize any costs relating to new products that had reached technological feasibility.  In the nine months ended September 30, 2013, the Company capitalized $30,000 of costs relating to new products that had reached technological feasibility.  In the three and nine months ended September 30, 2012, the Company capitalized zero and $56,000 of costs relating to new products that had reached technological feasibility, respectively.  For the three and nine months ended September 30, 2013, the Company recorded amortization expense of $12,000 and $70,000, respectively.  For the three and nine months ended September 30, 2012, the Company recorded amortization expense of $44,000 and $127,000, respectively.
	The Company also capitalizes costs related to internal use software and website application, infrastructure development and content development costs.  Costs related to preliminary project activities and post implementation activities are expensed as incurred.  Costs incurred during the application development stage are capitalized.  Internal-use software is amortized on a straight line basis over its estimated useful life, generally three years. Management evaluates the useful lives of these assets on an annual basis and tests for impairment whenever events or changes in circumstances occur that could impact the recoverability of these assets. The capitalized costs are included in “Property and equipment” in the condensed consolidated balance sheet. In each case the software or website is for internal needs, and the Company does not plan to market the software externally. For the three and nine months ended September 30, 2013, the Company capitalized approximately $14,000 and $156,000 of software and website development costs, respectively.  For the three and nine months ended September 30, 2012, the Company capitalized approximately $10,000 and $317,000 of software and website development costs, respectively.  For the three and nine months ended September 30, 2013, the Company recorded amortization expense of $175,000 and $519,000, respectively.  For the three and nine months ended September 30, 2012, the Company recorded amortization expense of $235,000 and $682,000, respectively.
Net Loss Per Share	'
	Net Loss Per Share
	Basic net loss per share is computed using the weighted-average number of common shares outstanding during the period.  Diluted net loss per share reflects the potential dilution of securities by adding common stock equivalents (computed using the treasury stock method) to the weighted-average number of common shares outstanding during the period, if dilutive. For the three and nine months ended September 30, 2013, stock options and awards exercisable for 2.2 million and 2.0 million shares of common stock along with common stock warrants exercisable for 4.4 million shares of common stock were excluded from the calculation of diluted net loss per share because their effect is anti-dilutive.
Recent Accounting Pronouncements	'
	Recent Accounting Pronouncements
	There are no material changes from the pronouncements disclosed in part II, Item 8 – “Financial Statements and Supplementary Data” of our Annual Report on Form 10-K for the year ended December 31, 2012.

Fair_Value_Measurements_Tables

Fair Value Measurements (Tables)	9 Months Ended
	Sep. 30, 2013
Schedule Of Changes In Fair Value Of Outstanding Common Stock Warrants	'
		Nine Months Ended September 30, 2013
	Balance at December 31, 2012	$	534
	Issuance of warrants with subordinated debt financing		698
	Total change in fair value		-380
	Balance at September 30, 2013	$	852
Summary Of Fair Value Of Assets And Liabilities Measured On A Recurring Basis	'
		30-Sep-13
		Level 1		Level 2		Level 3		Total
	Assets:
	Money market instruments	$	650	$	-	$	-	$	650
	Liabilities:
	Common stock warrants	$	-	$	-	$	852	$	852
PIPE Warrants [Member]	'
Schedule Of Assumptions To Determine Fair Value	'
	Expected life (in years)	3.5
	Risk-free interest rate	0.82	%
	Dividend yield	0	%
	Expected volatility	95	%
Sub-Debt Warrants [Member]	'
Schedule Of Assumptions To Determine Fair Value	'
	Expected life (in years)	2.6
	Risk-free interest rate	0.48	%
	Dividend yield	0	%
	Expected volatility	109	%

StockBased_Compensation_Tables

Stock-Based Compensation (Tables)	9 Months Ended
	Sep. 30, 2013
Stock-Based Compensation [Abstract]	'
Schedule Of Valuation Assumptions Used To Estimate Fair Value Of Stock Options Granted	'
		Three months ended September 30,		Nine months ended September 30,
		2013	2012	2013	2012
	Expected life (in years)	n/a	5.5	5.5	5.5
	Risk-free interest rate	n/a	0.8%	0.9%	1.0%
	Dividend yield	n/a	0%	0%	0%
	Expected volatility	n/a	63%	74%	63%

Commitments_And_Contingencies_

Commitments And Contingencies (Tables)	9 Months Ended
	Sep. 30, 2013
Commitments And Contingencies [Abstract]	'
Schedule Of Future Minimum Lease Payments And Future Payments Under Royalty Agreements	'
		Remaining 2013		2014		2015		2016		2017 and thereafter		Total
	Contractual Obligations:
	Lease obligations	$	197	$	670	$	624	$	229	$	155	$	1,875
	Minimum royalty obligations		-		150		-		-		-		150
	Total	$	197	$	820	$	624	$	229	$	155	$	2,025

Restructuring_Tables

Restructuring (Tables)	9 Months Ended
	Sep. 30, 2013
Restructuring [Abstract]	'
Schedule Of Accrual Costs	'
		As of September 30, 2013
	Accrued at December 31, 2012	$	285
	Charges		-
	Cash payments		-141
	Adjustments		-21
	Accrued at September 30, 2013	$	123

Long_Term_Debt_Tables

Long Term Debt (Tables)	9 Months Ended
	Sep. 30, 2013
Long Term Debt [Abstract]	'
Components Of Debt	'
			As of September 30, 2013
	Subordinated notes payable	$	4,600
	Deferred debt discount		-509
	Accrued PIK interest		277
	Long-term debt	$	4,368

Summary_Of_Significant_Account2

Summary Of Significant Accounting Policies (Details) (USD $)

0 Months Ended

9 Months Ended

3 Months Ended

9 Months Ended

3 Months Ended

9 Months Ended

3 Months Ended

9 Months Ended

3 Months Ended

9 Months Ended

Apr. 05, 2013

Sep. 30, 2013

Sep. 30, 2012

Aug. 09, 2013

Dec. 31, 2012

Dec. 31, 2011

Sep. 30, 2013

Sep. 30, 2012

Sep. 30, 2013

Sep. 30, 2012

Sep. 30, 2013

Sep. 30, 2012

Sep. 30, 2013

Sep. 30, 2012

Sep. 30, 2013

Sep. 30, 2013

Sep. 30, 2013

Sep. 30, 2013

segment

Software Development Costs [Member]

Software Development Costs [Member]

Software Development Costs [Member]

Software Development Costs [Member]

Internal Use Software And Website Development Costs [Member]

Internal Use Software And Website Development Costs [Member]

Internal Use Software And Website Development Costs [Member]

Internal Use Software And Website Development Costs [Member]

Stock Options [Member]

Stock Options [Member]

Warrant [Member]

Warrant [Member]

Summary Of Significant Accounting Policies [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Number of operating segments

'

1

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Cash and cash equivalents

'

$2,887,000

$2,617,000

'

$2,272,000

$5,871,000

'

'

'

'

'

'

'

'

'

'

'

'

Net cash used in operating activities

'

-2,917,000

-10,807,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Subordinated notes

4,600,000

4,600,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Number of securities called by warrants issued

1,846,940

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Interest rate of subordinated notes

12.00%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Subordinated notes maturity date

'

5-Apr-15

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Percentage of principal to be repaid in case of triggering event

'

101.00%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Line of credit facility, maximum amount borrowed under the agreement

'

'

'

4,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Cash pledged as collateral

'

150,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Capitalized software development costs during period

'

'

'

'

'

'

'

0

30,000

56,000

14,000

10,000

156,000

317,000

'

'

'

'

Property and equipment, estimated useful life

'

'

'

'

'

'

'

'

'

'

'

'

'P3Y

'

'

'

'

'

Amortization expense

'

'

'

'

'

'

$12,000

$44,000

$70,000

$127,000

$175,000

$235,000

$519,000

$682,000

'

'

'

'

Anti-dilutive securities

'

'

'

'

'

'

'

'

'

'

'

'

'

'

2,200,000

2,000,000

4,400,000

4,400,000

Warrant_Liability_Details

Warrant Liability (Details) (USD $)

3 Months Ended

9 Months Ended

3 Months Ended

9 Months Ended

0 Months Ended

3 Months Ended

9 Months Ended

0 Months Ended

Sep. 30, 2013

Sep. 30, 2012

Sep. 30, 2013

Sep. 30, 2012

Apr. 05, 2013

Dec. 31, 2012

Sep. 30, 2013

Sep. 30, 2013

Mar. 28, 2012

Sep. 30, 2013

Sep. 30, 2013

Apr. 05, 2013

Sep. 30, 2013

Warrant [Member]

Warrant [Member]

PIPE Warrants [Member]

PIPE Warrants [Member]

PIPE Warrants [Member]

Sub-Debt Warrants [Member]

Sub-Debt Warrants [Member]

Warrant Liability [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

Number of securities called by warrants issued

'

'

'

'

1,846,940

'

'

'

2,505,852

'

'

1,846,940

'

Warrants issued, exercise price

'

'

'

'

'

'

'

'

1.82

'

'

1.03

'

Warrants exercise period

'

'

'

'

'

'

'

'

'5 years

'

'

'3 years

'

Warrant liability

$852,000

'

$852,000

'

'

$534,000

'

'

'

$444,000

$444,000

$698,000

$408,000

Interest and other income (expense), net

($209,000)

$1,030,000

($140,000)

$1,095,000

'

'

$22,000

$290,000

'

$20,000

$90,000

'

'

Fair_Value_Measurements_Narrat

Fair Value Measurements (Narrative) (Details) (USD $)	Sep. 30, 2013	Dec. 31, 2012	Sep. 30, 2013	Sep. 30, 2013	Apr. 05, 2013
			PIPE Warrants [Member]	Sub-Debt Warrants [Member]	Sub-Debt Warrants [Member]
Warrant liability	$852,000	$534,000	$444,000	$408,000	$698,000
Sensitivity analysis, percentage of price change	'	'	10.00%	10.00%	'
Sensitivity analysis, change in price of common stock, percentage	'	'	16.00%	15.00%	'
Sensitivity analysis, change in price of common stock, value	'	'	70,000	70,000	'
Sensitivity analysis, percentage of volatility change	'	'	10.00%	10.00%	'
Sensitivity analysis, change in volatility, percentage	'	'	18.00%	14.00%	'
Sensitivity analysis, change in volatility, value	'	'	$80,000	$60,000	'

Fair_Value_Measurements_Schedu

Fair Value Measurements (Schedule Of Assumptions To Determine Fair Value Of Warrants) (Details)	9 Months Ended
	Sep. 30, 2013
PIPE Warrants [Member]	'
Fair Value Inputs, Equity, Quantitative Information [Line Items]	'
Expected life (in years)	'3 years 6 months
Risk-free interest rate	0.82%
Dividend yield	0.00%
Expected volatility	95.00%
Sub-Debt Warrants [Member]	'
Fair Value Inputs, Equity, Quantitative Information [Line Items]	'
Expected life (in years)	'2 years 7 months 6 days
Risk-free interest rate	0.48%
Dividend yield	0.00%
Expected volatility	109.00%

Fair_Value_Measurements_Schedu1

Fair Value Measurements (Schedule Of Changes In Fair Value Of Outstanding Common Stock Warrants) (Details) (USD $)	9 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2013
Fair Value Measurements [Abstract]	'
Balance at December 31, 2012	$534
Issuance of warrants with subordinated debt financing	698
Total change in fair value	-380
Balance at September 30, 2013	$852

Fair_Value_Measurements_Summar

Fair Value Measurements (Summary Of Fair Value Of Assets And Liabilities Measured On A Recurring Basis) (Details) (USD $)	Sep. 30, 2013
In Thousands, unless otherwise specified
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'
Money market instruments	$650
Common stock warrants	852
Level 1 [Member]	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'
Money market instruments	650
Level 2 [Member]	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'
Money market instruments	'
Common stock warrants	'
Level 3 [Member]	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'
Common stock warrants	$852

StockBased_Compensation_Narrat

Stock-Based Compensation (Narrative) (Details)	3 Months Ended		9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012
Stock-Based Compensation [Abstract]	'	'	'	'
Stock options granted	0	96,000	583,750	278,000
Restricted stock units granted	143,333	0	268,928	113,257

StockBased_Compensation_Schedu

Stock-Based Compensation (Schedule Of Valuation Assumptions Used To Estimate Fair Value Of Stock Options Granted) (Details)	3 Months Ended	9 Months Ended
	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012
Stock-Based Compensation [Abstract]	'	'	'
Expected life (in years)	'5 years 6 months	'5 years 6 months	'5 years 6 months
Risk-free interest rate	0.80%	0.90%	1.00%
Dividend yield	0.00%	0.00%	0.00%
Expected volatility	63.00%	74.00%	63.00%

Loan_Payable_Details

Loan Payable (Details) (USD $)	Sep. 30, 2013
Loan Payable [Abstract]	'
Outstanding line of credit	$0

Provision_For_Income_Taxes_Det

Provision For Income Taxes (Details) (USD $)	3 Months Ended		9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012
Provision For Income Taxes [Abstract]	'	'	'	'
Income tax expense	$27,000	$86,000	$74,000	$169,000
Unrecognized tax benefits	2,700,000	'	2,700,000	'
Unrecognized tax benefits that would affect the effective tax rate	$0	'	$0	'

Commitments_And_Contingencies_1

Commitments And Contingencies (Narrative) (Details) (USD $)	Sep. 30, 2013
Commitments And Contingencies [Abstract]	'
Capital lease arrangements, due in 2013	$101,000
Capital lease arrangements, due in 2014	25,000
Minimum royalty payments per year	$150,000

Commitments_And_Contingencies_2

Commitments And Contingencies (Schedule Of Future Minimum Lease Payments And Future Payments Under Royalty Agreements) (Details) (USD $)	Sep. 30, 2013
In Thousands, unless otherwise specified
Commitments And Contingencies [Abstract]	'
Lease obligations, remaining 2013	$197
Lease obligations, 2014	670
Lease obligations, 2015	624
Lease obligations, 2016	229
Lease obligations, 2017 and thereafter	155
Lease obligations, Total	1,875
Minimum royalty obligations, 2014	150
Minimum royalty obligations, Total	150
Total, remaining 2013	197
Total, 2014	820
Total, 2015	624
Total, 2016	229
Total, 2017 and thereafter	155
Total, Total	$2,025

Restructuring_Details

Restructuring (Details) (USD $)	3 Months Ended	9 Months Ended		12 Months Ended
	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012	Dec. 31, 2012
	employee
	item
Restructuring Cost and Reserve [Line Items]	'	'	'	'
Number of workforce reductions	2	'	'	'
Reduction in workforce, percentage	30.00%	'	'	'
Restructuring charges	$1,462,000	'	$1,462,000	$1,500,000
Payments for severance costs	'	'	'	1,100,000
Number of officers departed the Company	1	'	'	'
Accrued liabilities	'	1,849,000	'	1,981,000
Employee Severance [Member]	'	'	'	'
Restructuring Cost and Reserve [Line Items]	'	'	'	'
Accrued liabilities	'	$100,000	'	'

Restructuring_Schedule_Of_Accr

Restructuring (Schedule Of Accrual Costs) (Details) (USD $)	3 Months Ended	9 Months Ended		12 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012	Dec. 31, 2012
Restructuring [Abstract]	'	'	'	'
Accrued at December 31, 2012	'	$285	'	'
Restructuring charges	1,462	'	1,462	1,500
Cash payments	'	-141	'	'
Adjustments	'	-21	'	'
Accrued at September 30, 2013	'	$123	'	$285

Long_Term_Debt_Narrative_Detai

Long Term Debt (Narrative) (Details) (USD $)	0 Months Ended	3 Months Ended	9 Months Ended
	Apr. 05, 2013	Sep. 30, 2013	Sep. 30, 2013
Long Term Debt [Abstract]	'	'	'
Subordinated notes	$4,600,000	$4,600,000	$4,600,000
Number of securities called by warrants issued	1,846,940	'	'
Interest rate of subordinated notes	12.00%	'	'
Subordinated notes maturity date	'	'	5-Apr-15
Percentage of principal amount required to be repaid upon occurence of a change of control	'	101.00%	101.00%
Value of warrants issued	'	'	698,000
Debt issuance costs	'	'	118,000
Amortization expense	'	$15,000	$30,000

Long_Term_Debt_Components_Of_D

Long Term Debt (Components Of Debt) (Details) (USD $)	Sep. 30, 2013	Apr. 05, 2013
In Thousands, unless otherwise specified
Long Term Debt [Abstract]	'	'
Subordinated notes payable	$4,600	$4,600
Deferred debt discount	-509	'
Accrued PIK interest	277	'
Long term debt	$4,368	'

Subsequent_Events_Details

Subsequent Events (Details) (USD $)	Sep. 30, 2013	Dec. 31, 2012
Estimated business exit costs	$123,000	$285,000
Minimum [Member] | Subsequent Event [Member]	'	'
Estimated business exit costs	200,000	'
Maximum [Member] | Subsequent Event [Member]	'	'
Estimated business exit costs	$250,000	'